Lidocaine Hydrochloride Topical Solution USP, 4%, 50mL
Published 14 January 2022
Product
Lidocaine Hydrochloride Topical Solution USP, 4%, 50mL Batch numbers: 12636, 12639, 12868, 13057, 13061, 13260, 13510, 13626, 13969, 13971, 15338, 15344, 16265, 16375 and 16470 Supplied via Special Access Scheme (SAS)
Why it was recalled
The Lidocaine Hydrochloride topical solution can become stronger than intended.
Hazard
An increased dose of Lidocaine could lead to the development of local anaesthetic toxicity and this may result in serious adverse health effects.
Source: Product Safety Australia. RecallMatch AU provides a screening summary and is independent of the ACCC.